News and Events - 2004 Archive

Press Releases - 2004

December 20, 2004 Commonwealth Biotechnologies Completes Acquisition of Fairfax Identity Labs  (Visit Fairfax Identity Labs)

November 23, 2004 Commonwealth Biotechnologies Acquires Leading DNA Profiling Company - Fairfax Identity Labs

November 15, 2004 Commonwealth Biotechnologies, Inc. Retires Industrial Revenue Bonds Used to Build Its Facility

November 1, 2004 CBI Posts Record Revenues & Profitability Through the Third Quarter

September 30, 2004 Commonwealth Biotechnologies, Inc. to Participate in NCI Sponsor Clinical Trial - Conduct of Molecular Screening Assays for Early Detection of Bladder Cancer Genetic Markers

September 29, 2004 Commonwealth Biotechnologies, Inc. Adds New Contracts; Announces Renewal of 5 Year Development Contract with IITRI - $ 1.5 Million in New Contracts brings 2004 Signing Totals to over $ 8 million

September 07, 2004 Commonwealth Biotechnologies, Inc. Teams with Fisher Scientific to Sell its Services and Products - Distribution and Service Agreement Puts Fisher Sales Force to Work for CBI As seen on USA Today

August 26, 2004 Commonwealth Biotechnologies, Inc. Names New Director - Dr. Gerald Krueger has Extensive Military Research Experience

August 12, 2004 Commonwealth Biotechnologies, Inc. Announces $ 2.0 Million of New Business Contracts - Focus in Core Competency Areas

July 29, 2004 Commonwealth Biotechnologies, Inc. Posts Profitable Second Quarter - Fourth Consecutive Quarter of Net Income

July 6, 2004 Commonwealth Biotechnologies Demands Halting of Trading of its Common Stock on the Berlin-Bremen Stock Exchange

July 1, 2004 New Initiatives at Commonwealth Biotechnologies, Inc. - Biosafety Lab Expansion, Patent Issuance; New Product Line

July 1, 2004 New Contracts at Commonwealth Biotechnologies, Inc. - Focus is in Bio Defense Related Work

May 27, 2004 Commonwealth Biotechnologies, Inc. Closes $2.5M Private Placement - Investment Expected to Enhance Company’s Bio-Defense Capabilities and Marketing Efforts

May 11, 2004 Commonwealth Biotechnologies, Inc. Announces Contract Signings Company Pipeline Continues to Increase

April 26, 2004 Commonwealth Biotechnologies, Inc. Retains Jesup and Lamont Securities Corp to Identify Investment Capital

March 31, 2004 Auditors Remove “Going Concern” Consideration for Commonwealth Biotechnologies, Inc. - Company’s Financial Condition Shows Dramatic Improvement

March 30, 2004 Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative - Signs Broad Teaming Agreement with DynPort Vaccine Company LLC.

March 29, 2004 Vistronix, Inc. and Commonwealth Biotechnologies, Inc. jointly extend contract with Department of the Army to Provide Secure Correspondence Screening Services

March 08, 2004 New Bio-Defense Related Contract Work at Commonwealth Biotechnologies, Inc.

February 04, 2004 Commonwealth Biotechnologies, Inc. Posts Consecutive Profitable Quarters; Closes 2003 with Positive Cash Flow

January 28, 2004 Commonwealth Biotechnologies, Inc. Receives Notice of Allowance for Sepsis Patent

---